|
December 6, 2005 Categories: Blogroll Posted by admin
VANCOUVER, April 20 /PRNewswire-FirstCall/ – Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) corporate partner Boston Scientific (“BSC”) today announced that six articles related to its pivotal TAXUS IV clinical trial were published in the April 19 edition of the prestigious Journal of American College of Cardiology (JACC), with the launch of a special issue devoted to the TAXUS IV trial.
Full news
|
|
